DISCONTINUATION

You have access
Longterm Retention Rate and Risk Factors for Adalimumab Discontinuation Due To Efficacy and Safety in Japanese Patients with Rheumatoid Arthritis: An Observational Cohort Study
Yosuke Hattori, Toshihisa Kojima, Atsushi Kaneko, Daihei Kida, Yuji Hirano, Takayoshi Fujibayashi, Kenya Terabe, Yuichiro Yabe, Hiroyuki Miyake, Takefumi Kato, Hideki Takagi, Masatoshi Hayashi, Takayasu Ito, Yasuhide Kanayama, Takeshi Oguchi, Nobunori Takahashi, Hisato Ishikawa, Koji Funahashi and Naoki Ishiguro

The Journal of Rheumatology August 1 2016, 43 (8) 1475-1479; DOI: https://doi.org/10.3899/jrheum.151006
You have access
Why Do Patients with Chronic Inflammatory Rheumatic Diseases Discontinue Their Biologics? An Assessment of Patients’ Adherence Using a Self-report Questionnaire
Anne-Laure Betegnie, Aurélie Gauchet, Audrey Lehmann, Laurent Grange, Matthieu Roustit, Magalie Baudrant, Pierrick Bedouch and Benoît Allenet

The Journal of Rheumatology April 1 2016, 43 (4) 724-730; DOI: https://doi.org/10.3899/jrheum.150414
You have access
Incidence and Predictors of Biological Antirheumatic Drug Discontinuation Attempts among Patients with Rheumatoid Arthritis in Remission: A CORRONA and NinJa Collaborative Cohort Study
Kazuki Yoshida, Helga Radner, Maria D. Mjaavatten, Jeffrey D. Greenberg, Arthur Kavanaugh, Mitsumasa Kishimoto, Kazuo Matsui, Masato Okada, George Reed, Yukihiko Saeki, Shigeto Tohma, Joel Kremer and Daniel H. Solomon

The Journal of Rheumatology December 1 2015, 42 (12) 2238-2246; DOI: https://doi.org/10.3899/jrheum.150240

Main menu

User menu

Search

DISCONTINUATION

Content

Resources

Subscribers

More